false
0000101538
UNITED STATES ANTIMONY CORP
0000101538
2025-11-12
2025-11-12
0000101538
UAMY:CommonStockOneMember
2025-11-12
2025-11-12
0000101538
UAMY:CommonStockTwoMember
2025-11-12
2025-11-12
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 12, 2025
| UNITED STATES ANTIMONY CORPORATION |
| (Exact name of registrant as specified in its charter) |
| Texas |
001-08675 |
81-0305822 |
|
(State or other jurisdiction
of incorporation) |
(Commission
File Number) |
(IRS Employer
Identification No.) |
| 4438 W. Lovers Lane, Unit 100, Dallas, TX 75209 |
| (Address of principal executive offices and zip code) |
Registrant’s telephone number, including
area code: (406) 606-4117
Former name or former address, if changed since last report: Not
Applicable
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ |
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ¨ |
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ¨ |
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: |
| Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered |
| Common Stock, $0.01 par value |
UAMY |
NYSE American |
| Common Stock, $0.01 par value |
UAMY |
NYSE Texas |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02 Results of Operations and Financial
Condition.
On November 12, 2025, United States Antimony Corporation
(“USAC,” “US Antimony Corporation,” or the “Company”) issued a press release reporting its financial
and operational results for the Third Quarter and Nine Months Ended September 30, 2025 (“Press Release”). This Press Release
is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The foregoing disclosure is qualified in its entirety
by the full text of the Press Release.
The information under this Item 2.02, including
Exhibit 99.1, of this Current Report on Form 8-K is being furnished and shall not be deemed “filed” for purposes of Section
18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that
section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended,
or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such
a filing.
This Press Release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations and assumptions
and involve risks and uncertainties that could cause actual results to differ materially. For a discussion of these risks, please refer
to the Company’s filings with the Securities and Exchange Commission. The Company disclaims any obligation to subsequently revise
any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated
or unanticipated events, except as required by law.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. |
|
Description |
| 99.1 |
|
Press Release issued by United States Antimony Corporation dated November 12, 2025 |
| 104 |
|
Cover Page Interactive Data File (embedded with the inline XBRL document) |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
| |
UNITED STATES ANTIMONY CORPORATION |
| |
|
|
| Dated: November 12, 2025 |
By: |
/s/ Richard R. Isaak |
| |
|
Richard R. Isaak |
| |
|
SVP, Chief Financial Officer |
